Financials
- Market Capitalization 205.8 M
- Employee 71
- Founded 2000
- CEO N/A
- Website www.alphacognition.com
- Headquarter British Columbia, Canada
- FIGI BBG011CJPRD0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.44
ratio cours/chiffre d'affaires
9.32
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3589 | ANTX AN2 Therapeutics, Inc. - Common Stock | 5.50 USD | -0.90% | -2.65% | +2.04% | +391.07% | 207.55 M USD | ||
| 3591 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.10 USD | -0.73% | -7.24% | +7.61% | -43.60% | 207.28 M USD | ||
| 3605 | IPHA Innate Pharma S.A. - American Depositary Shares | 2.14 USD | -1.38% | -4.46% | +22.29% | +2.88% | 200.56 M USD | ||
| 3611 | CUE Cue Biopharma, Inc. - Common Stock | 27.49 USD | +7.72% | +4.01% | +1.81% | +3336.25% | 199.70 M USD |